FG 7142: is this validated tool to study anxiety now forgotten?

R Horowski1

  • 1Antaxios GmbH, Zum Weiher 44, 14552, Wildenbruch, Germany. r.horowski@antaxios.de.

Summary

FG 7142, a novel drug, induced severe anxiety attacks in its first human trial. This finding suggests its potential as a tool for future anxiety research.

Related Concept Videos

Generalized Anxiety Disorder01:30

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
574